Mariner Investment Group’s Kite Pharma, Inc. KITE Stock Holding History

Mariner Investment Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,300	Closed	-$465K	–	139
2016 Q2	$465K	Sell	9,300 -4,700	-34%	-$231K	0.16%	97
2016 Q1	$643K	Sell	14,000 -7,007	-33%	-$339K	0.18%	109
2015 Q4	$1.29M	Sell	21,007 -5,000	-19%	-$352K	0.29%	105
2015 Q3	$1.45M	Buy	26,007 +13,500	+108%	+$849K	0.29%	95
2015 Q2	$763K	Buy	12,507 +500	+4%	+$28.5K	0.2%	118
2015 Q1	$693K	Sell	12,007 -8,000	-40%	-$536K	0.19%	109
2014 Q4	$1.15M	Buy	20,007 +3,500	+21%	+$147K	0.2%	106
2014 Q3	$470K	Buy	+16,507	New	+$408K	0.1%	144

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mariner Investment Group's KITE Position: Q3 2016 in Review

Mariner Investment Group sold out of Kite Pharma, Inc. (KITE) in Q3 2016, closing a stake of 9,300 shares — an estimated $465K sold.

Mariner Investment Group first reported a position in KITE in Q3 2014 and held it in 8 quarters. The position peaked at $1.45M in Q3 2015. 195 funds tracked by Wall St. Rank hold KITE as of Q3 2016.

Mariner Investment Group reported no remaining Kite Pharma, Inc. position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 9,300 Kite Pharma, Inc. shares in Q3 2016, an estimated $465K.
Mariner Investment Group first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 8 quarters.
Mariner Investment Group's Kite Pharma, Inc. position peaked at $1.45M in Q3 2015.
195 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.